Medplus Q1FY27 revenue rises 21.8%, PAT falls 21.7%

2 min read     Updated on 23 Jul 2026, 05:19 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Medplus Health Services reported a 21.8% YoY increase in revenue to ₹18,796 million for Q1FY27, but net profit fell 21.7% to ₹331.7 million due to margin contraction. The retail segment drove revenue, while diagnostics showed strong EBITDA growth. The Board approved ₹1,550 million in capital expenditure plans and appointed a new Company Secretary. The AGM is scheduled for August 17, 2026, with remote e-voting available from August 10, 2026.

powered bylight_fuzz_icon
45674383

*this image is generated using AI for illustrative purposes only.

Medplus Health Services reported a 21.8% year-on-year increase in revenue to ₹18,796 million for the quarter ended June 30, 2026 (Q1FY27). Despite the top-line growth, net profit after tax (PAT) declined by 21.7% to ₹331.7 million, impacted by margin contraction. The Board of Directors approved the unaudited standalone and consolidated financial results on July 21, 2026, along with significant capital expenditure plans totalling ₹1,550 million. Subsequently, the company submitted the audio recording of the earnings call held on July 22, 2026, with analysts and institutional investors to discuss these results.

Financial Performance

The revenue growth was primarily driven by the retail segment, which contributed ₹18,423.92 million. However, the gross margin contracted by 160 basis points year-on-year to 24.5%, attributed to a lower sales mix of private label products and lower margins realized in the franchisee business. The operating EBITDA margin fell to 3.5% from 4.7% in the prior year, while the EBITDA margin stood at 7.1% compared to 8.47% in the corresponding period of the previous year.

Metric Q1 FY27 Q1 FY26 YoY Change
Revenue ₹18,796.0 million ₹15,426.3 million +21.8%
Gross Margin 24.5% 26.1% -160 bps
EBITDA ₹1.33 billion ₹1.31 billion
EBITDA Margin 7.1% 8.47%
Operating EBITDA ₹651.2 million ₹728.1 million -10.6%
Operating EBITDA Margin 3.5% 4.7% -120 bps
PAT ₹331.7 million ₹423.5 million -21.7%

Segment Performance

The retail segment saw its operating EBITDA drop by 14.8% year-on-year to ₹588.1 million, with margins shrinking to 3.2%. Conversely, the diagnostics segment showed strong growth, with revenue rising 22.4% to ₹370.8 million and operating EBITDA increasing 59.5% to ₹65.9 million.

Strategic Updates

The Board approved a CAPEX plan of approximately ₹400 million for Optival Health Solutions Private Limited, a material subsidiary, to set up a Food Park including a Cold Press Oil Extraction Unit at Hyderabad. Additionally, the company approved an investment of approximately ₹1,150 million to establish a Concierge Health & Wellness Services Facility in Hyderabad, comprising capital expenditure of ₹900 million. The Board also appointed Mr. Shrenik Soni as Company Secretary and Compliance Officer effective July 21, 2026.

Regulatory Filings

The company submitted newspaper clippings of the unaudited financial results published in the Financial Express and Nava Telangana on July 22, 2026, to the BSE and NSE. Furthermore, the Board scheduled the Twentieth Annual General Meeting (AGM) for Monday, August 17, 2026, at 03:30 P.M. via Video Conferencing. Remote e-voting facilities will be available to members as on the cut-off date of August 10, 2026.

Historical Stock Returns for Medplus Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.91%-1.48%-16.02%-21.77%-24.92%-38.43%

What is the expected timeline for the new CAPEX projects to become accretive to earnings?

Will the company adjust its pricing strategy to recover the gross margins lost in the franchisee business?

How will the ₹1,550 million capital expenditure impact the company's free cash flow and debt levels in the near term?

Medplus Health Services
View Company Insights
View All News
like18
dislike

Medplus Health Services keeps CAPEX plans in abeyance

1 min read     Updated on 23 Jul 2026, 12:04 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Medplus Health Services Limited has decided to keep its previously approved CAPEX plans in abeyance following a Board meeting on July 23, 2026. The decision impacts the proposed Food Park by Optival Health Solutions Private Limited and a Concierge Health & Wellness Services Facility in Hyderabad. The company stated that this move will not adversely affect existing operations or business performance.

powered bylight_fuzz_icon
46334031

*this image is generated using AI for illustrative purposes only.

Medplus Health Services Limited has decided to keep its previously approved capital expenditure plans in abeyance following a review of the present business structure and market outlook. The Board of Directors, at its meeting held on July 23, 2026, resolved to pause the implementation of two key projects approved just two days prior on July 21, 2026. The company confirmed that this decision is not expected to have any adverse impact on its existing operations or business performance.

Details of the Suspended Projects

The Board specifically halted the progress on two distinct initiatives. The first involves the setting up of a Food Park by Optival Health Solutions Private Limited, which is a material subsidiary of the company. The second project pertains to the establishment of a Concierge Health & Wellness Services Facility located in Hyderabad, Telangana.

Project Entity / Location Status
Food Park Optival Health Solutions Private Limited (Material Subsidiary) Kept in abeyance
Concierge Health & Wellness Services Facility Hyderabad, Telangana Kept in abeyance

Strategic Evaluation

Despite the suspension of these specific expansion activities, Medplus Health Services Limited indicated that it will continue to evaluate future growth opportunities. The company maintains that the abeyance of the CAPEX Plan is a strategic decision based on current assessments and does not signal a negative outlook for the company's operational stability.

The meeting, which commenced at 11:15 AM and concluded at 11:40 AM, was convened to assess these capital allocation strategies. The filing was submitted to the BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Medplus Health Services

1 Day5 Days1 Month6 Months1 Year5 Years
+0.91%-1.48%-16.02%-21.77%-24.92%-38.43%

What specific market conditions or structural changes prompted the Board to reverse the CAPEX approval so quickly?

How will the company reallocate the capital originally designated for the Food Park and Concierge Health projects?

Does this strategic pause indicate a broader shift in Medplus's expansion strategy for the remainder of the fiscal year?

Medplus Health Services
View Company Insights
View All News
like16
dislike

More News on Medplus Health Services

1 Year Returns:-24.92%